IL6 and Alzheimer disease: Our results manifested that the serum levels of C5a, TNF-α, IL-1β, IL-6 and CRP in AD patients were higher than those of the non-AD subjects, with the levels in severe AD patients facilitated compared with those of mild and moderate AD patients, while there was no significant differences in these levels between mild and moderate AD patients.